The new test, called Genedrive 96 SARS-CoV-2 assay, is being developed for use on polymerase chain reaction (PCR) instruments in laboratories.
Designed as a one-step, ready-to-go freeze-dried assay, the test leverages Genedrive’s PCR chemistry along with Cytiva’s LyoStable stabilisation technology.
The combination is expected to facilitate high-throughput manufacturing of more than 10,000 tests per hour with a 96-well, temperature-stable plate format that does not require refrigeration.
